Scholars Central

OtherPublished 23 Jul 2016

Parathyroid hormone replacement in hypoparathyroidism

Authors: Sharon H Chou, Tamara Vokes

Clinical Investigation

Volume 5 · Issue 5 · Pages 501–507

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Hypoparathyroidism results from insufficient parathyroid hormone (PTH) to maintain normal serum levels of calcium and phosphate. Unlike most endocrine deficiency disorders, the current standard of treatment is not replacement with PTH but supplementation with calcium and vitamin D. Normal physiology cannot be fully restored with calcium and vitamin D, and long-term complications of this treatment include impaired renal function, nephrolithiasis and ectopic soft tissue calcification. In the last decade clinical studies have emerged using PTH for the treatment of hypoparathyroidism either in place of or in addition to standard treatment with calcium and vitamin D. The effects of PTH replacement on biochemical indices, bone metabolism and quality of life have been promising.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Clinical Investigation.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical Investigation
  • SubjectGeneral & Internal Medicine
  • BylineArticles whose byline prints “Sharon H Chou”
  • BylineArticles whose byline prints “Tamara Vokes”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels